Latest Insights VIEW MORE

  • Previous Close 4.4200
  • Open 4.4500
  • Bid 3.3000 x 200
  • Ask 5.6700 x 200
  • Day's Range 4.3850 - 4.5900
  • 52 Week Range 2.7800 - 6.4500
  • Volume 119,341
  • Avg. Volume 449,921
  • Market Cap (intraday) 356.921M
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) --
  • EPS (TTM) -2.1100
  • Earnings Date (est.) Aug 6, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 8.67

Related Tickers

PRLD Prelude Therapeutics Incorporated
4.1385 -3.08%
 
KPTI Karyopharm Therapeutics Inc.
8.56 +4.90%
 
ERNA Ernexa Therapeutics Inc.
11.52 -3.93%
 
CNTX Context Therapeutics Inc.
2.5650 -1.35%
 
NUVL Nuvalent, Inc.
104.18 +2.02%
 
KOD Kodiak Sciences Inc.
36.47 +0.66%
 
CLYM Climb Bio Inc
11.27 +2.41%
 
AGIO Agios Pharmaceuticals, Inc.
27.83 -1.10%
 
VSTM Verastem, Inc.
4.3000 +1.42%
 
MLYS Mineralys Therapeutics, Inc.
30.51 +2.21%
 

Recent Events

May 12, 2026 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 27, 2026 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 5, 2026 at 12:00 AM UTC

10-K: Periodic Financial Reports

January 8, 2026 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 12, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 7, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

June 20, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 12, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 29, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

April 17, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Performance

Performance Overview: AVIR

Trailing total returns as of 5/26/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AVIR
24.93%
S&P 500 (^GSPC)
9.72%

1-Year Return

AVIR
53.79%
S&P 500 (^GSPC)
29.43%

3-Year Return

AVIR
4.70%
S&P 500 (^GSPC)
78.60%

5-Year Return

AVIR
77.79%
S&P 500 (^GSPC)
79.00%

Financials

(Values in U.S. thousands)
Next
  12-2025 12-2024 12-2023 12-2022 12-2021
Sales 0 0 0 0 351,367
Gross Profit N/A N/A N/A N/A 351,367
Operating Expenses 180,887 192,950 164,162 130,650 212,990
Operating Income -180,887 -192,950 -164,162 -130,650 138,377
Other Income 16,376 25,490 29,224 11,151 213
Pre-tax Income -164,511 -167,460 -134,938 -119,499 138,590
Income Tax -6,162 925 1,018 -3,590 17,400
Net Income Continuous -158,349 -168,385 -135,956 -115,909 121,190
Net Income $-158,349 $-168,385 $-135,956 $-115,909 $121,190
EPS Basic Total Ops -1.94 -2.00 -1.63 -1.39 1.46
EPS Basic Continuous Ops -1.94 -2.00 -1.63 -1.39 1.46
EPS Diluted Total Ops -1.94 -2.00 -1.63 -1.39 1.37
EPS Diluted Continuous Ops -1.94 -2.00 -1.63 -1.39 1.37
EPS Diluted Before Non-Recurring Items -1.94 -2.00 -1.63 -1.39 1.37
EBITDA(a) $-185,415 $-204,355 $-179,192 $-135,855 $138,406
(Values in U.S. thousands)
Next
  03-2026 12-2025 09-2025 06-2025 03-2025
Operating Expenses 48,008 54,934 45,567 41,345 39,041
Operating Income -48,008 -54,934 -45,567 -41,345 -39,041
Other Income 2,618 3,299 3,714 4,391 4,972
Pre-tax Income -45,390 -51,635 -41,853 -36,954 -34,069
Income Tax 50 -6,768 196 207 203
Net Income Continuous -45,440 -44,867 -42,049 -37,161 -34,272
Net Income $-45,440 $-44,867 $-42,049 $-37,161 $-34,272
EPS Basic Total Ops -0.57 -0.57 -0.53 -0.44 -0.40
EPS Basic Continuous Ops -0.57 -0.57 -0.53 -0.44 -0.40
EPS Diluted Total Ops -0.57 -0.57 -0.53 -0.44 -0.40
EPS Diluted Continuous Ops -0.57 -0.57 -0.53 -0.44 -0.40
EPS Diluted Before Non-Recurring Items N/A -0.57 -0.53 -0.44 -0.40
EBITDA(a) $-48,485 $-55,638 $-46,538 $-42,562 $-40,677
(Values in U.S. thousands)
Next
  12-2025 12-2024 12-2023 12-2022 12-2021
Assets
Current Assets
Cash & Cash Equivalents 95,713 64,696 143,823 188,460 764,375
Marketable Securities 206,117 390,025 434,283 458,249 N/A
TOTAL $310,991 $462,355 $590,455 $660,922 $772,403
Non-Current Assets
PPE Net 457 873 1,289 1,705 23
Other Non-Current Assets 3,770 1,440 3,224 4,081 466
TOTAL $4,227 $2,313 $4,513 $5,786 $489
Total Assets $315,218 $464,668 $594,968 $666,708 $772,892
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 12,945 4,458 4,252 2,551 4,534
Accrued Expenses 25,996 13,345 27,364 15,206 52,152
TOTAL $39,784 $18,603 $32,376 $18,478 $56,883
Non-Current Liabilities
Other Non-Current Liabilities 0 842 1,642 2,403 0
TOTAL $N/A $7,198 $7,400 $7,658 $5,932
Total Liabilities $39,784 $25,801 $39,776 $26,136 $62,815
Shareholders' Equity
Shares Outstanding, K 79,672 85,525 84,165 83,342 83,226
Common Shares 78 84 83 83 83
Retained earnings -522,569 -364,220 -195,835 -59,879 56,030
Other shareholders' equity 174 233 207 -684 0
TOTAL $275,434 $438,867 $555,192 $640,572 $710,077
Total Liabilities And Equity $315,218 $464,668 $594,968 $666,708 $772,892
(Values in U.S. thousands)
Next
  03-2026 12-2025 09-2025 06-2025 03-2025
Assets
Current Assets
Cash & Cash Equivalents 79,317 95,713 77,344 87,721 119,394
Marketable Securities 176,689 206,117 251,965 291,992 306,042
TOTAL $263,197 $310,991 $336,138 $385,604 $433,708
Non-Current Assets
PPE Net 353 457 561 665 769
Other Non-Current Assets 3,526 3,770 6,264 5,336 5,487
TOTAL $3,879 $4,227 $6,825 $6,001 $6,256
Total Assets $267,076 $315,218 $342,963 $391,605 $439,964
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 9,446 12,945 3,515 8,844 7,387
Accrued Expenses 23,287 25,996 15,828 10,454 13,549
TOTAL $33,367 $39,784 $20,175 $20,119 $21,747
Non-Current Liabilities
Other Non-Current Liabilities 0 0 213 425 634
TOTAL $N/A $N/A $7,008 $7,070 $7,133
Total Liabilities $33,367 $39,784 $27,183 $27,189 $28,880
Shareholders' Equity
Shares Outstanding, K 80,027 79,672 78,127 79,358 85,579
Common Shares 80 78 78 81 85
Retained earnings -568,009 -522,569 -477,702 -435,653 -398,492
Other shareholders' equity -97 174 238 37 118
TOTAL $233,709 $275,434 $315,780 $364,416 $411,084
Total Liabilities And Equity $267,076 $315,218 $342,963 $391,605 $439,964
(Values in U.S. thousands)
Next
  12-2025 12-2024 12-2023 12-2022 12-2021
Cash Flows From Operating Activities
Net Income -158,349 -168,385 -135,956 -115,909 121,190
Depreciation Amortization -4,528 -11,405 -15,030 -5,205 29
Accounts payable and accrued liabilities 8,487 206 1,701 -1,983 10,289
Other Working Capital 16,482 -7,476 16,163 -46,586 -247,845
Other Operating Activity 5,877 51,561 47,727 48,701 29,332
Operating Cash Flow $-132,031 $-135,499 $-85,395 $-120,982 $-87,005
Cash Flows From Investing Activities
Change In Deposits 188,793 56,105 40,303 -453,467 N/A
PPE Investments N/A N/A N/A -1,943 -4
Investing Cash Flow $188,793 $56,105 $40,303 $-455,410 $-4
Cash Flows From Financing Activities
Common Stock Issued 259 267 257 370 1,465
Common Stock Repurchased -25,519 N/A N/A N/A N/A
Other Financing Activity -485 0 0 0 0
Financing Cash Flow $-25,745 $267 $257 $370 $1,465
Beginning Cash Position 64,696 143,823 188,658 764,680 850,224
End Cash Position 95,713 64,696 143,823 188,658 764,680
Net Cash Flow $31,017 $-79,127 $-44,835 $-576,022 $-85,544
Free Cash Flow
Operating Cash Flow -132,031 -135,499 -85,395 -120,982 -87,005
Capital Expenditure N/A N/A N/A -1,943 -4
Free Cash Flow -132,031 -135,499 -85,395 -122,925 -87,009
(Values in U.S. thousands)
Next
  03-2026 12-2025 09-2025 06-2025 03-2025
Cash Flows From Operating Activities
Net Income -45,440 -158,349 -113,482 -71,433 -34,272
Depreciation Amortization -477 -4,528 -3,824 -2,853 -1,636
Accounts payable and accrued liabilities -3,499 8,487 -943 4,386 2,929
Other Working Capital -4,203 16,482 -2,637 -765 -1,606
Other Operating Activity 7,228 5,877 17,078 7,232 4,022
Operating Cash Flow $-46,391 $-132,031 $-103,808 $-63,433 $-30,563
Cash Flows From Investing Activities
Change In Deposits 29,738 188,793 142,201 324,266 85,608
PPE Investments N/A N/A N/A -223,368 N/A
Investing Cash Flow $29,738 $188,793 $142,201 $100,898 $85,608
Cash Flows From Financing Activities
Common Stock Issued 257 259 -226 -347 -347
Common Stock Repurchased N/A -25,519 -25,519 -14,093 N/A
Other Financing Activity 0 -485 0 0 0
Financing Cash Flow $257 $-25,745 $-25,745 $-14,440 $-347
Beginning Cash Position 95,713 64,696 64,696 64,696 64,696
End Cash Position 79,317 95,713 77,344 87,721 119,394
Net Cash Flow $-16,396 $31,017 $12,648 $23,025 $54,698
Free Cash Flow
Operating Cash Flow -46,391 -132,031 -103,808 -63,433 -30,563
Capital Expenditure N/A N/A N/A -223,368 N/A
Free Cash Flow -46,391 -132,031 -103,808 -286,801 -30,563

Research

Analysis

Earnings Estimate

GAAP
Normalized
Currency in USD
Current Qtr. (Jun 2026)
Next Qtr. (Sep 2026)
Current Year (2026)
Next Year (2027)
No. of Analysts 2 2 2 2
Avg. Estimate -0.56 -0.55 -1.92 -1.38
Low Estimate -0.56 -0.58 -2.2 -1.65
High Estimate -0.55 -0.51 -1.65 -1.12
Year Ago EPS -0.44 -0.53 -1.94 -1.92

Revenue Estimate

Currency in USD
Current Qtr. (Jun 2026)
Next Qtr. (Sep 2026)
Current Year (2026)
Next Year (2027)
No. of Analysts 1 1 2 2
Avg. Estimate -- -- -- 30.17M
Low Estimate -- -- -- --
High Estimate -- -- -- 60.34M
Year Ago Sales -- -- -- --
Sales Growth (year/est) 0.00% 0.00% 0.00% 0.00%

Earnings History

GAAP
Normalized
Currency in USD
6/30/2025
9/30/2025
12/31/2025
3/31/2026
EPS Est. -0.41 -0.41 -0.49 -0.56
EPS Actual -0.44 -0.53 -0.57 --
Difference -0.03 -0.12 -0.08 --
Surprise % -6.02% -27.71% -17.53% --

EPS Trend

GAAP
Normalized
Currency in USD
Current Qtr. (Jun 2026)
Next Qtr. (Sep 2026)
Current Year (2026)
Next Year (2027)
Current Estimate -0.56 -0.55 -1.92 -1.38
7 Days Ago -0.56 -0.55 -1.93 -1.38
30 Days Ago -0.56 -0.55 -1.93 -1.38
60 Days Ago -0.56 -0.55 -1.93 -1.38
90 Days Ago -0.52 -0.46 -1.75 -1.2

EPS Revisions

GAAP
Normalized
Currency in USD
Current Qtr. (Jun 2026)
Next Qtr. (Sep 2026)
Current Year (2026)
Next Year (2027)
Up Last 7 Days 2 1 1 1
Up Last 30 Days 2 1 1 1
Down Last 7 Days -- -- -- 1
Down Last 30 Days -- -- -- 1

Growth Estimates

Symbol Current Qtr.Next Qtr.Current YearNext Year
AVIR -26.14%-2.83%0.77%28.05%
S&P 500 25.56%19.62%22.34%16.42%